Loading...
•
Sep 30, 2021
Paysign Q3 2021 Earnings Report
Reported significant improvements in revenue and operating results.
Key Takeaways
Paysign reported a solid Q3 2021 with improvements in revenue, loss from operations, EBITDA, and adjusted EBITDA both sequentially and year-over-year. Total revenue for the quarter was $7.8 million, a 16.8% increase from the previous quarter. The company is raising its gross profit margin forecast by 250 basis points to 49.0%.
Total revenue for the quarter was $7.8 million, up 16.8% from the second quarter of 2021.
Adjusted EBITDA experienced an almost threefold increase over the same period.
Gross profit margin forecast raised by 250 basis points to 49.0%.
Balance sheet improved sequentially as a result of this quarter’s performance.
Paysign
Paysign
Forward Guidance
Paysign anticipates continued business improvement in Q4 2021, with sequential revenue dollar growth similar to Q3. Gross profit margin forecast is raised to 49.0%.
Positive Outlook
- Sequential revenue dollar growth expected to be similar to Q3.
- Gross profit margin forecast raised by 250 basis points to 49.0%.
- Operating expenses are expected to remain flat or increase slightly.
- Plasma volumes remain at or better than current levels.
- Adjusted EBITDA forecast is now expected to be in the range of $1.3 million to $1.9 million
Challenges Ahead
- Residual effects of the pandemic continue to impact the business.
- Sequential increases in operating expenses expected due to seasonal operational expenditures in Q4.
- COVID-19 related labor shortages at plasma donation centers.
- Border closures and other effects continue to weigh on the company’s results of operations.
- Uncertainty around the extent and timing of the potential future spread or mitigation of COVID-19 and variants.